Walleye Trading LLC Vertex Pharmaceuticals Inc Call Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Call Options

26 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $15.7 Million - $17.2 Million	34,100 Added 947.22%	37,700 $17.5 Million
Q2 2024 Aug 14, 2024	SELL	$392.81 - $485.53 $3.5 Million - $4.32 Million	-8,900 Reduced 71.2%	3,600 $1.69 Million
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $4.2 Million - $4.59 Million	-10,300 Reduced 45.18%	12,500 $5.23 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $1.61 Million - $1.93 Million	4,700 Added 25.97%	22,800 $9.28 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $1.66 Million - $1.78 Million	4,900 Added 37.12%	18,100 $6.29 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $2.45 Million - $2.74 Million	-7,800 Reduced 37.14%	13,200 $4.65 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $169,938 - $193,860	600 Added 2.94%	21,000 $6.62 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $1.37 Million - $1.54 Million	-4,800 Reduced 19.05%	20,400 $5.89 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $1.2 Million - $1.34 Million	4,400 Added 21.15%	25,200 $7.3 Million
Q2 2022 Aug 08, 2022	SELL	$234.96 - $292.55 $17.3 Million - $21.6 Million	-73,700 Reduced 77.99%	20,800 $5.86 Million
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $18.9 Million - $22.3 Million	85,500 Added 950.0%	94,500 $24.7 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $885,050 - $1.12 Million	-5,000 Reduced 35.71%	9,000 $1.98 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $3.79 Million - $4.24 Million	-20,900 Reduced 59.89%	14,000 $2.54 Million
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $712,462 - $840,180	-3,800 Reduced 9.82%	34,900 $7.04 Million
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $6.46 Million - $7.53 Million	31,200 Added 416.0%	38,700 $8.32 Million
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $3.13 Million - $4.17 Million	-15,100 Reduced 66.81%	7,500 $1.77 Million
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $1.1 Million - $1.3 Million	4,300 Added 23.5%	22,600 $6.15 Million
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $180,384 - $236,640	-800 Reduced 4.19%	18,300 $5.31 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $2.98 Million - $3.69 Million	-14,900 Reduced 43.82%	19,100 $4.55 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $2.73 Million - $3.67 Million	-16,400 Reduced 32.54%	34,000 $7.44 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $1.31 Million - $1.48 Million	7,900 Added 18.59%	50,400 $8.54 Million
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $3.16 Million - $3.66 Million	19,200 Added 82.4%	42,500 $7.79 Million
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $1.26 Million - $1.5 Million	7,700 Added 49.36%	23,300 $4.29 Million
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $2.13 Million - $2.69 Million	14,000 Added 875.0%	15,600 $2.59 Million
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $150,957 - $173,466	900 Added 128.57%	1,600 $308,000
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $102,004 - $118,972	700 New	700 $119,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$10.9 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$9.45 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$8.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$4.82 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$3.67 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account